PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 153 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2016. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $2,448,000 | -22.2% | 238,617 | +649.7% | 0.12% | -24.8% |
| Q4 2017 | $3,146,000 | +60.2% | 31,829 | +94.1% | 0.16% | +66.7% |
| Q3 2017 | $1,964,000 | -4.1% | 16,400 | -70.2% | 0.10% | -2.9% |
| Q1 2017 | $2,049,000 | -38.3% | 55,102 | +11.3% | 0.10% | -45.5% |
| Q3 2016 | $3,319,000 | – | 49,500 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avalon Global Asset Management LLC | 30,000 | $3,503,000 | 2.29% |
| WEATHERBIE CAPITAL, LLC | 141,123 | $16,476,000 | 1.67% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $663,918,000 | 1.66% |
| BB BIOTECH AG | 521,991 | $60,942,000 | 1.65% |
| CORNERSTONE CAPITAL MANAGEMENT LLC | 317,032 | $37,013,000 | 1.21% |
| Orbimed Advisors | 940,800 | $109,838,000 | 0.81% |
| Perceptive Advisors | 100,000 | $11,675,000 | 0.70% |
| Ghost Tree Capital, LLC | 17,500 | $2,043,000 | 0.66% |
| CAPITAL INTERNATIONAL LTD /CA/ | 90,935 | $10,617,000 | 0.63% |
| Fernwood Investment Management, LLC | 6,800 | $794,000 | 0.62% |